New patent expiration for APGDI drug MYRBETRIQ

   May 4, 2024    Comments Off on New patent expiration for APGDI drug MYRBETRIQ    Posted in: Uncategorized

Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…
Source

Continue reading

New patent for Global Blood drug OXBRYTA

   May 4, 2024    Comments Off on New patent for Global Blood drug OXBRYTA    Posted in: Patent Added

Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. It is available from one supplier. There are ten…
Source

Continue reading
Biotechblog